Loading clinical trials...
Loading clinical trials...
This is purpose of this study is to evaluate the safety, tolerability, and effect on Albuminuria of MZE829 in Adults with APOL1 Kidney Disease
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Maze Therapeutics
NCT07355296 · Proteinuric Kidney Diseases
NCT06794996 · Proteinuric Kidney Disease
NCT07224776 · Proteinuric Renal Disease, Proteinuric Kidney Disease, and more
Research Site
Decatur, Alabama
Research Site
Huntsville, Alabama
Research Site
Montgomery, Alabama
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions